ACL
SWAV

APEIRON Capital Ltd’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

APEIRON Capital Ltd’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,700
Closed -$2.83M – 19
2024
Q1 		$2.83M Sell
8,700
-9,600
-52% -$2.36M 1.43% 10
2023
Q4 		$3.49M Hold
18,300
– – 5.13% 6
2023
Q3 		$3.64M Buy
+18,300
New +$4.33M 2.44% 7
2023
Q2 		– Sell
-5,100
Closed -$1.11M – 16
2023
Q1 		$1.11M Buy
+5,100
New +$994K 0.62% 11

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

APEIRON Capital Ltd's SWAV Position: Q2 2024 in Review

APEIRON Capital Ltd sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 8,700 shares — an estimated $2.83M sold.

APEIRON Capital Ltd first reported a position in SWAV in Q1 2023 and held it in 4 quarters. The position peaked at $3.64M in Q3 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • APEIRON Capital Ltd reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • APEIRON Capital Ltd sold 8,700 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $2.83M.
  • APEIRON Capital Ltd first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2023 and held it in 4 quarters.
  • APEIRON Capital Ltd's Shockwave Medical, Inc. Common Stock position peaked at $3.64M in Q3 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on APEIRON Capital Ltd's 13F filing for Q2 2024, filed 9 Aug 2024.